Showing 1,521–1,540 of 18,047 drug recalls
Drug Recall
Ongoing
Historical record Class II
LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53427-124-01 by Neogen Corporation
Reason
CGMP violations. Recall initiated
October 8, 2024 Reported by FDA
December 4, 2024 Distribution
Product sold directly to one distributor consignee, Bob Barker Company, an American company that sells supplies to prisons, jails, and other institutions.
View recall →
Drug Recall
Terminated
Historical record Class II
PARCHE LEON PAIN RELIEVING HOT PATCH, Camphor 3%, Menthol 1.25%, Capsaicin 0.025%, 6 patches per box, Distributed by: Pharmadel LLC, Georgetown, DE 19947 NDC 55758-039-01, UPC 8 59424 00433 6 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
CHEEKY BONSAI PAIN RELIEF PATCHES, Menthol 10%, 4 patches per box, Distributed by Cheeky Bonsai, San Francisco, CA UPC 8 60006 57564 9 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
JR WATKINS COOLING PAIN RELIEF PATCHES, Menthol 7.5%, 5 patches per box, Distributed By: J.R. Watkins, LLC, Oakland, CA 94612 UPC 8 56294 00878 5 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
LILAS Feminine Pain Relief Patch, Menthol 10%, a) 5 patches per box (UPC 7 87099 48212 1) and 10 patches per box (UPC 7 87099 48211 4), Distributed by: Lilas Wellness, Inc., Beaverton, Oregon 97008-7105 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
EQUATE MAXIMUM STRENGTH LIDOCAINE PAIN RELIEVING PATCH Lidocaine 4% Topical Anesthetic, 6 patches per box PATCHES, LIDOCAINE 4%, Distributed by: Walmart Inc., Bentonville, AR 72716 NDC 79903-106-06 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
HealthWise PERIOD PATCH Menstrual Pain Relief, Menthol 10%, 10 patches per box, Manufactured for Veridian Healthcare, LLC, Gurnee, IL 60031 NDC 71101-947-10, UPC 8 45717 01072 6 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031 NDC 71101-954-05, UPC 8 45717 00818 1 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC 8 45717 01056 6), Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
ABSORBINE JR PAIN RELIEVING KNEE PATCH, Camphor 7%, Menthol 7%, packaged in a) 1 patch (UPC 8 89476 41251 3) and b) 6 patches (UPC 8 89476 41306 0), Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
ABSORBINE jr ULTRA STRENGTH PAIN PATCH, Menthol 6.5%, 1 patch per box, Distributed By: Absorbine Jr. LLC, Chattanooga, TN 37402 UPC 8 89476 41318 3, UPC 8 89476 41336 7 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, 1 extra large patch per box, Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 UPC 8 89476 41218 6, UPC 8 89476 41236 0 by Unexo Life Sciences Private Limited
Reason
cGMP Deviations Recall initiated
October 24, 2024 Reported by FDA
December 4, 2024 Distribution
Nationwide in the US
View recall →
Drug Recall
Terminated
Historical record Class II
Lisinopril Tablets, USP 10 mg, 90 tablets per bottle, Rx Only, Distributed by: Walmart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC# 68645-610-90. by Evaric Pharmaceuticals Inc.
Reason
Presence of Foreign Object: A pharmacist discovered a metal fragment embedded in a lisinopril 10 mg tablet. Recall initiated
November 15, 2024 Reported by FDA
November 27, 2024 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01 by Safecor Health, LLC
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. Recall initiated
November 11, 2024 Reported by FDA
November 27, 2024 Distribution
USA nationwide.
View recall →
Drug Recall
Ongoing
Historical record Class II
Calcium Carbonate Chewable 500 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-106-01 by Safecor Health, LLC
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. Recall initiated
November 11, 2024 Reported by FDA
November 27, 2024 Distribution
USA nationwide.
View recall →
Drug Recall
Ongoing
Historical record Class II
Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01 by Safecor Health, LLC
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. Recall initiated
November 11, 2024 Reported by FDA
November 27, 2024 Distribution
USA nationwide.
View recall →
Drug Recall
Ongoing
Historical record Class II
Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01 by Safecor Health, LLC
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. Recall initiated
November 11, 2024 Reported by FDA
November 27, 2024 Distribution
USA nationwide.
View recall →
Drug Recall
Ongoing
Historical record Class II
Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-104-01 by Safecor Health, LLC
Reason
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity. Recall initiated
November 11, 2024 Reported by FDA
November 27, 2024 Distribution
USA nationwide.
View recall →
Drug Recall
Ongoing
Historical record Class II
Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3 by Noven Pharmaceuticals Inc
Reason
Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive). Recall initiated
October 31, 2024 Reported by FDA
November 27, 2024 Distribution
USA nationwide.
View recall →
Drug Recall
Terminated
Historical record Class II
Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India by Lupin Pharmaceuticals Inc.
Reason
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor Recall initiated
October 23, 2024 Reported by FDA
November 27, 2024 Distribution
Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
View recall →
Data last updated: October 31, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
